KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Rigel Pharmaceuticals (RIGL) Other Gross PP&E Adjustments: 2011-2025

Historic Other Gross PP&E Adjustments for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Sep 2025 value amounting to -$1.1 million.

  • Rigel Pharmaceuticals' Other Gross PP&E Adjustments fell 159.26% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year decrease of 412.11%. This contributed to the annual value of $107,000 for FY2024, which is 89.38% down from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$1.1 million for Q3 2025, which was up 10.87% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of $9.7 million in Q4 2022 and a low of -$15.9 million during Q1 2021.
  • For the 3-year period, Rigel Pharmaceuticals' Other Gross PP&E Adjustments averaged around -$656,636, with its median value being -$997,000 (2023).
  • In the last 5 years, Rigel Pharmaceuticals' Other Gross PP&E Adjustments surged by 366.20% in 2021 and then tumbled by 159.26% in 2025.
  • Rigel Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at $6.8 million in 2021, then surged by 42.56% to $9.7 million in 2022, then slumped by 89.64% to $1.0 million in 2023, then slumped by 89.38% to $107,000 in 2024, then plummeted by 159.26% to -$1.1 million in 2025.
  • Its last three reported values are -$1.1 million in Q3 2025, -$1.2 million for Q2 2025, and -$1.3 million during Q1 2025.